NVAX NOVAVAX INC Disposals and divestitures 8-K Filing 2024 - Asset Sale Novavax Inc. completed the sale of its biologics manufacturing campus in Czech Republic to Novo Nordisk for $200 million, receiving $180 million in cash and assuming certain liabilities. The sale included land, equipment, contracts, and employees associated with the facility.Get access to all SEC 8-K filings of the NOVAVAX INC